Technology Catalysts International
username
client login
password
Technology Catalysts International is a multinational consulting company specializing in technology licensing and assessment, small company acquisitions, technical and business research.
Technology Catalysts
Technology Catalysts

Merger, Acquisition, and Divestiture Support

Technology Catalysts provides a full range of merger, acquisition, and divestiture services, including:
  • Acquisition Due Diligence
  • Acquisition Study
  • Plant Divestiture
TCI's Merger & Acquisition Support Services (MASS) are used across the entire spectrum of M&A activities-- from setting of objectives to final deal negotiation. MASS differs from other M&A consulting in several important ways:
  • TCI focuses on technology-driven chemical, pharmaceutical, advanced material, and related industries.
  • TCI does not charge commissions or success fees.
  • TCI is represented in all areas of the world through its network of offices and affiliates.


For additional information regarding TCI’s Merger & Acquisition Support Service, please visit our Services Section.


Example Projects include:

Thermochromic Inks
TCI conducted due diligence for a proposed acquisition by an international client. The target company manufactures and sells thermochromic pigments. We reported on the target’s technology-base, competing offerings, and market potential. Finally, TCI developed an overall valuation of the technology and offered a recommendation regarding this opportunity.

Biopharmaceutical Facility Sale
TCI assisted Glaxo Wellcome Biofarma (GWB) in the sale of its biopharmaceutical facility in Porriño, Spain. Although the primary objective was to safeguard jobs and secure the site as a biotech manufacturing facility, GWB received a very attractive purchase offer for the property, which also met the primary objectives and was close to the valuation placed on the plant by TCI.

Electroplating Additives
A European client was approached with a possible opportunity to enter the electroplating additives business via acquisition of several small market participants. To correctly consider these opportunities, they needed a better understanding of the electroplating additives business. The primary finding of TCI’s research was that, while the potential acquisitions and participation in the electroplating additives business met some of their strategic objectives, it failed to satisfy at least two key criteria. TCI suggested that the client consider acquisition of a much larger target as an approach most likely to provide it with a leadership role in the business.

Biocides and Cosmetic Ingredients
TCI’s client manufactures a line of specialty biocides and cosmetic ingredients in North America. To meet their strategic objective of doubling sales in these specialty chemical product lines over the next two years, they commissioned TCI to assist in an acquisition effort restricted to Europe and Asia. From an initial list of over 100 candidates, ten target companies - four in Asia and six in Europe - were identified as meeting the client’s strategic objectives.

Technology Catalysts
Technology Catalysts Technology Catalysts Technology Catalysts Technology Catalysts




Contact Us | Privacy | Sitemap Copyright © 2008 Technology Catalysts International Technology Catalysts